‘Pharma Bro’ Shkreli Calls SLS Results ‘Sketch,’ Compares Leukemia Vaccine Data To Capricor’s Deramiocel
Martin Shkreli dismissed SLS’s trial data as statistically fragile, drawing a parallel between the company’s data and Capricor Therapeutics’ Deramiocel data.